aspirin and niacin

aspirin has been researched along with niacin in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	14 (22.22)	18.7374
1990's	8 (12.70)	18.2507
2000's	22 (34.92)	29.6817
2010's	19 (30.16)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bohlin, L; Huss, U; Perera, P; Ringbom, T; Vasänge, M	1
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Ekins, S; Williams, AJ; Xu, JJ	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Hoffer, A	1
Fowler, SF; Hainer, BL; Price, SO; Whelan, AM	1
Dodobaeva, MS; Khamidov, NKh	1
Becker, G	1
Wu, BJ; Wu, Y	1
Borhani, NO	1
Sheleg, VA	1
Berge, KG; Canner, PL; Friedewald, W; Friedman, L; Prineas, RJ; Stamler, J; Wenger, NK	1
Popov, AI	1
Kovaleva, LG; Krasiukova, LI; Sedova, GT	1
Dupuis, D; Lotte, C; Roguet, R; Rougier, A	1
Bogdanets, LI; Ikhaev, ZA; Il'in, VN; Sharonin, GV; Stepanov, NV	1
Catron, PW; Flynn, ET	1
Stamler, J	1
Jayakrishnan, A; Sunny, MC; Thanoo, BC	1
Campbell, JR; Jungnickel, PW; Maloley, PA; Peddicord, TE; Vander Tuin, EL	1
Barel, A; Clarys, P; Taeymans, J	1
Davis, KB; Egan, DA; Garg, R; Griffin, B; Pettinger, MB; Thomason, T; Waclawiw, MA	1
Isles, CG; Paterson, JR	1
Applegate, WB; Crouse, JR; Davis, KB; Egan, D; Elam, MB; Garg, R; Herd, JA; Hunninghake, DB; Johnson, WC; Kennedy, JW; Kostis, JB; Sheps, DS	1
Gedye, A	1
Balakin, AA; Dodonov, AF; Novikova, LI; Talrose, VL	1
Doskina, EV	1
Ito, MK; Pieper, JA; Talbert, RL	1
CARLANDER, OA; OHLSSON, WT	1
DUTHIE, JJ; TRUELOVE, LH	1
HAINING, CG	1
CARLSON, LA; OSTMAN, J	1
Cheng, K; Gottesdiener, K; Lai, E; Metters, K; O'Neill, G; Sturino, C; Wang, Z; Waters, MG; Wright, SD; Wu, KK; Wu, TJ	1
Baccara-Dinet, M; Oberwittler, H	1
Kamanna, VS; Kashyap, ML; Liu, P; Meyers, CD	1
Rembold, CM	1
Cefali, EA; Kissling, CJ; McGovern, ME; Simmons, PD; Stanek, EJ	1
Bartzatt, R; Cirillo, JD; Cirillo, SL	1
Crumley, TM; De Lepeleire, I; Gottesdiener, K; Lai, E; Liu, F; Michiels, N; O'Neill, G; Vets, E; Wagner, JA; Wenning, LA	1
Athyros, VG; Hatzitolios, A; Kakafika, AI; Karagiannis, A; Mikhailidis, DP; Pagourelias, ED; Skaperdas, A; Tziomalos, K	1
Boucher, W; Kempuraj, D; Papaliodis, D; Theoharides, TC	1
Alves, JD; Darioli, R; Hostalek, U; Steinhagen-Thiessen, E; Vogt, A	1
Ambegaonkar, BM; Kamal-Bahl, S; Watson, DJ	1
Atiee, GJ; Dishy, V; Ebel, DL; Lai, E; Liu, F; Paolini, JF; Reilley, S; Royalty, J; Wagner, JA	1
Jiang, P; Kashyap, ML; Krause, SL; Lewin, AJ; Padley, RJ; Thakkar, RB	1
Arora, R; Sood, A	1
Jacobson, TA	1
Casulari, LA; Dos Santos, AM; Salgado, BJ; Salgado, JV	1
Ballantyne, CM; Dong, JF; Kimball, KT; Lumsden, AB; Morrisett, JD; Nambi, V; Saunders, J; Virani, SS	1
Bazou, D; Cantwell, P; Gilmer, JF; Harmon, S; Inkielewicz, I; Jones, M; Ledwidge, M; Medina, C; Radomski, MW; Santos-Martinez, MJ	1
Cefali, G; Gilmer, JF; Harmon, S; Jones, M; Kerins, DM; Ledwidge, MT; O'Connell, D; Ryan, F	1
Higashi, N; Katayama, Y; Nakajima, N; Ueda, M	1
Harangi, M; Paragh, G; Zsíros, N	1
Alavi, A; deGoma, EM; Dunbar, RL; Litt, HI; Mehta, NN; Mohler, ER; Pollan, L; Rader, DJ; Saboury, B; Salavati, A; Schoen, M; Shinohara, RT; Torigian, DA; Woo, J	1
Ben Salem, C; Fathallah, N; Hmouda, H; Slim, R	1
Duncton, MA; Singh, R	1
Banka, SS; Kaafarani, H; Lee, J; Levine, A; Lin, H; Thachil, R	1
Jaffa, FM; Johnson, E; Kalyani, RR; Shubrook, JH; Skolnik, N	1

Reviews

11 review(s) available for aspirin and niacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Adjuvant drug therapy for decompression sickness: a review. Undersea biomedical research, 1982, Volume: 9, Issue:2 Topics: Adrenal Cortex Hormones; Animals; Anti-Arrhythmia Agents; Aspirin; Bronchodilator Agents; Coumarins; Cyproheptadine; Decompression Sickness; Dextrans; Diazepam; Dipyridamole; Fluid Therapy; Heparin; Humans; Indomethacin; Levodopa; Niacin; Vasoconstrictor Agents; Vasodilator Agents	1982
[Percutaneous penetration of drugs--application in physical therapy]. Sportverletzung Sportschaden : Organ der Gesellschaft fur Orthopadisch-Traumatologische Sportmedizin, 1997, Volume: 11, Issue:4 Topics: Administration, Oral; Administration, Topical; Animals; Aspirin; Dogs; Humans; Niacin; Physical Therapy Modalities; Salicylates; Skin Absorption	1997
Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy. QJM : monthly journal of the Association of Physicians, 2000, Volume: 93, Issue:9 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dietary Supplements; Female; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Life Style; Male; Middle Aged; Niacin; Patient Selection; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Simvastatin; Triglycerides	2000
Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment. International journal of clinical practice, 2006, Volume: 60, Issue:6 Topics: Aspirin; Dose-Response Relationship, Drug; Dyslipidemias; Flushing; Humans; Hypolipidemic Agents; Niacin; Prostaglandin Antagonists	2006
To statin or to non-statin in coronary disease--considering absolute risk is the answer. Atherosclerosis, 2007, Volume: 195, Issue:1 Topics: Acute Coronary Syndrome; Aspirin; Atherosclerosis; Cholesterol, LDL; Coronary Artery Disease; Diet; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Niacin; Risk	2007
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia? Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:14 Topics: Aspirin; Drug Combinations; Dyslipidemias; Health Services Needs and Demand; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipidemias; Niacin	2007
Mechanisms of flushing due to niacin and abolition of these effects. Journal of clinical hypertension (Greenwich, Conn.), 2009, Volume: 11, Issue:11 Topics: Aspirin; Dose-Response Relationship, Drug; Dyslipidemias; Humans; Hypolipidemic Agents; Indoles; Niacin; Pruritus	2009
A "hot" topic in dyslipidemia management--"how to beat a flush": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention. Mayo Clinic proceedings, 2010, Volume: 85, Issue:4 Topics: Aspirin; Attitude to Health; Coronary Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyslipidemias; Flushing; Humans; Hypolipidemic Agents; Medication Adherence; Niacin; Patient Compliance; Prognosis; Time Factors	2010
[Clinical significance of and treatment options for increased lipoprotein(a)]. Orvosi hetilap, 2014, Apr-20, Volume: 155, Issue:16 Topics: Aspirin; Biomarkers; Blood Component Removal; Cardiovascular Diseases; Carrier Proteins; Cholesterol Ester Transfer Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoprotein(a); Niacin; Oligonucleotides; Proprotein Convertase 9; Proprotein Convertases; Risk Factors; Serine Endopeptidases	2014
Drug-induced hyperuricaemia and gout. Rheumatology (Oxford, England), 2017, 05-01, Volume: 56, Issue:5 Topics: Androgens; Antitubercular Agents; Aspirin; Carbohydrates; Cytotoxins; Diuretics; Gout; Humans; Hyperuricemia; Immunosuppressive Agents; Niacin; Sodium Lactate; Testosterone; Uric Acid	2017

Trials

15 trial(s) available for aspirin and niacin

Article	Year
The effect of aspirin on niacin-induced cutaneous reactions. The Journal of family practice, 1992, Volume: 34, Issue:2 Topics: Adult; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Flushing; Humans; Hyperlipidemias; Male; Niacin; Pilot Projects; Pruritus	1992
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Journal of the American College of Cardiology, 1986, Volume: 8, Issue:6 Topics: Adult; Aspirin; Clofibrate; Dextrothyroxine; Estrogens; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Niacin; Time Factors	1986
Pharmacological trials: primary and secondary prevention of coronary heart disease. Preventive medicine, 1983, Volume: 12, Issue:1 Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone	1983
Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions. Journal of general internal medicine, 1997, Volume: 12, Issue:10 Topics: Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Flushing; Humans; Hyperemia; Male; Middle Aged; Niacin; Pruritus; Reference Values; Skin Diseases	1997
Compliance to multiple interventions in a high risk population. Annals of epidemiology, 1999, Volume: 9, Issue:7 Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Aspirin; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Male; Niacin; Patient Compliance; Peripheral Vascular Diseases; Placebos; Platelet Aggregation Inhibitors; Pravastatin; Time Factors; Warfarin	1999
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease. American heart journal, 2000, Volume: 140, Issue:5 Topics: Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Arteriosclerosis; Aspirin; Cholesterol, LDL; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Niacin; Platelet Aggregation Inhibitors; Pravastatin; Risk Factors; Self Medication; Time Factors; Treatment Outcome; Triglycerides; Vitamins; Warfarin	2000
Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation. International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:2 Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Flushing; Humans; Hypolipidemic Agents; Male; Niacin; Treatment Outcome	2007
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clinical pharmacology and therapeutics, 2007, Volume: 81, Issue:6 Topics: Adolescent; Adult; Aspirin; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Indoles; Male; Middle Aged; Niacin; Receptors, Immunologic; Receptors, Prostaglandin; Regional Blood Flow; Skin; Vasodilation; Vasodilator Agents	2007
Influence of the timing of low-dose aspirin on tolerability of prolonged-release nicotinic acid in patients at elevated cardiovascular risk. Current medical research and opinion, 2008, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Cholesterol, HDL; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Female; Flushing; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Platelet Aggregation Inhibitors; Risk Factors	2008
Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms. Journal of clinical pharmacology, 2009, Volume: 49, Issue:4 Topics: Administration, Oral; Adult; Aged; Aspirin; Cross-Over Studies; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Flushing; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Niacin; Placebos; Receptors, Immunologic; Receptors, Prostaglandin	2009
Acetylsalicylic acid reduces niacin extended-release-induced flushing in patients with dyslipidemia. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2009, Volume: 9, Issue:2 Topics: Administration, Oral; Adult; Aged; Aspirin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Dyslipidemias; Female; Flushing; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Vasodilator Agents	2009
Effects of low-dose of niacin associated to simvastatin in the treatment of mixed dyslipidemia Salgad. Minerva cardioangiologica, 2010, Volume: 58, Issue:5 Topics: Aged; Aspirin; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Drug Combinations; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Metabolic Syndrome; Middle Aged; Niacin; Platelet Aggregation Inhibitors; Prospective Studies; Simvastatin; Vasodilator Agents	2010
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. Journal of vascular surgery, 2011, Volume: 53, Issue:3 Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arachidonic Acid; Aspirin; Azetidines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lower Extremity; Male; Middle Aged; Niacin; Peripheral Arterial Disease; Placebo Effect; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Stents; Time Factors; Treatment Outcome	2011
A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography. Academic radiology, 2015, Volume: 22, Issue:5 Topics: Aorta; Aspirin; Atherosclerosis; Carotid Arteries; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Hypolipidemic Agents; Inflammation; Lipids; Magnetic Resonance Spectroscopy; Male; Multimodal Imaging; Niacin; Pilot Projects; Placebos; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Randomized controlled trial of different aspirin regimens for reduction of niacin-induced flushing. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2017, Jun-15, Volume: 74, Issue:12 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Flushing; Humans; Male; Niacin; Vasodilator Agents	2017

Other Studies

37 other study(ies) available for aspirin and niacin

Article	Year
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay. Journal of natural products, 2002, Volume: 65, Issue:11 Topics: Acrolein; Alkaloids; Animals; Anthraquinones; Aspirin; Biological Assay; Catalysis; Cinnamomum zeylanicum; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Eugenol; Flavonoids; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Kinetics; Lactones; Models, Molecular; Nitrobenzenes; Oleanolic Acid; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Steroids; Sulfonamides; Sulfones; Syzygium; Terpenes; Triterpenes; Ursolic Acid	2002
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds. Bioorganic & medicinal chemistry, 2007, Nov-15, Volume: 15, Issue:22 Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption	2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Niacin reaction. The Journal of family practice, 1992, Volume: 34, Issue:6 Topics: Aspirin; Flushing; Humans; Niacin	1992
[Secondary prevention of ischemic heart disease]. Klinicheskaia meditsina, 1991, Volume: 69, Issue:1 Topics: Adult; Aged; Aspirin; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Niacin	1991
Managing lipid disorders. Iowa medicine : journal of the Iowa Medical Society, 1990, Volume: 80, Issue:4 Topics: Aspirin; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Hypercholesterolemia; Niacin	1990
[Determination of aspirin and nicotinic acid in plasma when used in combination]. Yao xue xue bao = Acta pharmaceutica Sinica, 1989, Volume: 24, Issue:6 Topics: Animals; Aspirin; Drug Therapy, Combination; Female; Male; Niacin; Rabbits; Spectrophotometry, Ultraviolet	1989
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases. Cardiology, 1985, Volume: 72, Issue:5-6 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone	1985
[Use of fibrinolysis activators and inhibitors in the complex treatment of patients with acute pneumonia]. Vrachebnoe delo, 1986, Issue:6 Topics: Acute Disease; Adolescent; Adult; Aged; Antifibrinolytic Agents; Aspirin; Drug Therapy, Combination; Female; Fibrinolysis; Humans; Male; Middle Aged; Niacin; Pneumonia	1986
[Effect of the nonspecific prevention of thrombogenic complications on late results in the combined treatment of bladder cancer]. Meditsinskaia radiologiia, 1987, Volume: 32, Issue:2 Topics: Adult; Aged; Aspirin; Combined Modality Therapy; Female; Follow-Up Studies; Gamma Rays; Humans; Male; Middle Aged; Niacin; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Thrombosis; Urinary Bladder; Urinary Bladder Neoplasms	1987
[Preventive correction of hemostasis in patients with polycythemia vera]. Gematologiia i transfuziologiia, 1986, Volume: 31, Issue:2 Topics: Aspirin; Humans; Niacin; Pentoxifylline; Polycythemia Vera; Theobromine; Thrombosis	1986
The measurement of the stratum corneum reservoir. A predictive method for in vivo percutaneous absorption studies: influence of application time. The Journal of investigative dermatology, 1985, Volume: 84, Issue:1 Topics: Animals; Aspirin; Benzoates; Benzoic Acid; Carbon Radioisotopes; Epidermis; Female; Niacin; Rats; Rats, Inbred Strains; Skin Absorption; Theophylline; Time Factors	1985
[Postoperative antithrombotic therapy in acute occlusion of the major arteries of the extremities]. Vestnik khirurgii imeni I. I. Grekova, 1980, Volume: 125, Issue:9 Topics: Acute Disease; Adolescent; Adult; Aged; Arm; Arterial Occlusive Diseases; Aspirin; Dextrans; Female; Heparin; Humans; Leg; Male; Middle Aged; Niacin; Nicotinic Acids; Pentoxifylline; Postoperative Care; Recurrence; Thrombosis	1980
Controlled release of oral drugs from cross-linked polyvinyl alcohol microspheres. The Journal of pharmacy and pharmacology, 1993, Volume: 45, Issue:1 Topics: Aspirin; Body Fluids; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Delayed-Action Preparations; Glutaral; Griseofulvin; Microscopy, Electron, Scanning; Microspheres; Niacin; Particle Size; Polyvinyl Alcohol	1993
Hypothesized treatment for migraines using low doses of tryptophan, niacin, calcium, caffeine, and acetylsalicylic acid. Medical hypotheses, 2001, Volume: 56, Issue:1 Topics: Adult; Aspirin; Caffeine; Calcium; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Middle Aged; Migraine Disorders; Niacin; Tryptophan	2001
The solvent shells of cluster ions produced by direct electric field extraction from glycerol/water mixtures. Rapid communications in mass spectrometry : RCM, 2001, Volume: 15, Issue:7 Topics: Algorithms; Amino Acids; Ascorbic Acid; Aspartic Acid; Aspirin; Glutamic Acid; Glycerol; Hydrocarbons, Halogenated; Ions; Membranes; Models, Theoretical; Molecular Structure; Niacin; Salicylic Acid; Spectrometry, Mass, Electrospray Ionization; Water	2001
[A case of familial restrictive cardiomyopathy]. Klinicheskaia meditsina, 2002, Volume: 80, Issue:9 Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Aspirin; Atenolol; Atrial Fibrillation; Cardiomyopathy, Restrictive; Cardiotonic Agents; Echocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Niacin; Platelet Aggregation Inhibitors; Potassium Magnesium Aspartate; Propranolol; Time Factors; Vasodilator Agents	2002
Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studies. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Jul-01, Volume: 60, Issue:13 Suppl 2 Topics: Aspirin; Atenolol; Blood Chemical Analysis; Coronary Disease; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Niacin; Obesity; Risk Factors; Simvastatin	2003
[Clinical trial of pabegan in rheumatoid arthritis]. Svenska lakartidningen, 1959, May-15, Volume: 56, Issue:20 Topics: 4-Aminobenzoic Acid; Arthritis; Arthritis, Rheumatoid; Ascorbic Acid; Aspirin; Niacin; Nicotinic Acids; Vitamins	1959
Effect of aspirin on cutaneous response to the local application of an ester of nicotinic acid. Annals of the rheumatic diseases, 1959, Volume: 18 Topics: Aspirin; Furans; Niacin; Nicotinic Acids; Skin	1959
EFFECTS OF ANTI-RHEUMATIC COMPOUNDS AND PYRIDINE DERIVATIVES ON THE CUTANEOUS RESPONSE TO THURFYL NICOTINATE IN THE GUINEA-PIG. British journal of pharmacology and chemotherapy, 1963, Volume: 21 Topics: Animals; Antirheumatic Agents; Aspirin; Flushing; Furans; Guinea Pigs; Niacin; Nicotinic Acids; Pharmacology; Phenylbutazone; Research; Skin; Sodium Salicylate; Ultraviolet Rays	1963
INHIBITION OF THE MOBILIZATION OF FREE FATTY ACIDS FROM ADIPOSE TISSUE IN DIABETES. II. EFFECT OF NICOTINIC ACID AND ACETYLSALICYLATE ON BLOOD GLUCOSE IN HUMAN DIABETICS. Acta medica Scandinavica, 1965, Volume: 178 Topics: Adipose Tissue; Aspirin; Blood Glucose; Diabetes Mellitus; Fatty Acids; Fatty Acids, Nonesterified; Glucose Tolerance Test; Humans; Lipid Metabolism; Niacin; Nicotinic Acids; Pharmacology	1965
Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proceedings of the National Academy of Sciences of the United States of America, 2006, Apr-25, Volume: 103, Issue:17 Topics: Adolescent; Adult; Animals; Aspirin; Female; Flushing; Humans; Hydantoins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Niacin; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Receptors, Immunologic; Receptors, Prostaglandin; Vasodilation	2006
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush. Atherosclerosis, 2007, Volume: 192, Issue:2 Topics: Aspirin; Calcimycin; Calcium; Flushing; Humans; Macrophages; Models, Biological; Niacin; Nicotinic Acids; Prostaglandin D2; Tumor Cells, Cultured	2007
Antibacterial activity of dipeptide constructs of acetylsalicylic acid and nicotinic acid. Drug delivery, 2007, Volume: 14, Issue:2 Topics: Ampicillin; Anti-Bacterial Agents; Aspirin; Chemistry, Pharmaceutical; Colony Count, Microbial; Dipeptides; Escherichia coli; Indicators and Reagents; Microbial Sensitivity Tests; Niacin; Penicillin Resistance; Penicillins	2007
The flavonoid luteolin inhibits niacin-induced flush. British journal of pharmacology, 2008, Volume: 153, Issue:7 Topics: Animals; Aspirin; Body Temperature; Disease Models, Animal; Flushing; Hypolipidemic Agents; Luteolin; Male; Niacin; Prostaglandin D2; Quercetin; Random Allocation; Rats; Rats, Sprague-Dawley; Serotonin; Skin	2008
Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interview. Clinical therapeutics, 2009, Volume: 31, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Data Collection; Female; Flushing; Humans; Hypolipidemic Agents; Incidence; Logistic Models; Male; Medication Adherence; Middle Aged; Niacin; Patient Education as Topic; Severity of Illness Index	2009
Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin. British journal of pharmacology, 2012, Volume: 166, Issue:3 Topics: Aspirin; Blood Platelets; Cell Communication; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Stability; Flow Cytometry; Humans; Isosorbide; Microscopy, Phase-Contrast; Niacin; Physostigmine; Platelet Aggregation; Prodrugs	2012
In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin? Atherosclerosis, 2012, Volume: 221, Issue:2 Topics: Animals; Apolipoproteins B; Aspirin; Blood Glucose; Chemistry, Pharmaceutical; Cholesterol, LDL; Cyclooxygenase Inhibitors; Hyperglycemia; Hypolipidemic Agents; Isosorbide; Lipid Metabolism; Lipids; Macaca fascicularis; Models, Biological; Niacin; Postprandial Period; Prodrugs; Prostaglandin D2; Salicylates; Thromboxane B2; Triglycerides	2012
Erythromelalgia associated with Clitocybe acromelalga intoxication. Clinical toxicology (Philadelphia, Pa.), 2013, Volume: 51, Issue:5 Topics: Aged; Aged, 80 and over; Aspirin; Erythromelalgia; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mushroom Poisoning; Niacin; Remission, Spontaneous	2013
A one-pot synthesis of tetrazolones from acid chlorides: understanding functional group compatibility, and application to the late-stage functionalization of marketed drugs. Organic & biomolecular chemistry, 2016, Oct-04, Volume: 14, Issue:39 Topics: Aspirin; Azides; Benzimidazoles; Benzoates; Bexarotene; Carboxylic Acids; Chemistry Techniques, Synthetic; Chlorides; Indomethacin; Niacin; Probenecid; Silanes; Telmisartan; Tetrahydronaphthalenes; Tetrazoles	2016
Reducing CV risk in diabetes: An ADA update. The Journal of family practice, 2017, Volume: 66, Issue:5 Topics: Antihypertensive Agents; Aspirin; Benzhydryl Compounds; Cardiovascular Diseases; Contraindications; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Chronotherapy; Ezetimibe; Fenofibrate; Glucosides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Liraglutide; Metformin; Niacin; PCSK9 Inhibitors; Platelet Aggregation Inhibitors; Risk Reduction Behavior; Thiazolidinediones	2017